Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30689082 | 1.00 | ERN1 (0.78) | ERN1PIM1 | |
| SCHEMBL6093685 | 0.88 | ERN1 (1.00) | ERN1PIM1 | |
| SCHEMBL3664243 | 0.84 | ERN1 (0.75) | ERN1 | |
| SCHEMBL29956081 | 0.84 | ERN1 (0.75) | ERN1 | |
| SCHEMBL294059 | 0.82 | ERN1 (1.00) | ERN1 | |
| SCHEMBL29382880 | 0.82 | ERN1 (1.00) | ERN1 | |
| SCHEMBL15057515 | 0.82 | ERN1 (0.64) | ERN1PIM1 | |
| SCHEMBL28337241 | 0.80 | ERN1 (0.96) | ERN1 | |
| SCHEMBL27998889 | 0.80 | ERN1 (0.96) | ERN1 | |
| SCHEMBL30294924 | 0.80 | ERN1 (0.96) | ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117233299-A | Method for detecting halogenated polyphenol in drinking water by solid phase extraction-vacuum centrifugal concentration-liquid chromatography tandem mass spectrometry | 浙江大学 | 2023-12-15 | — | — | CN | claimed |
| CN-104525265-A | 2,4-dihydroxy-5-chlorobenzaldehyde amino acid copper complex catalyst, and preparation method and application thereof | UNIV LIAOCHENG | 2015-04-22 | — | — | CN | claimed |
| EP-4619097-A1 | AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF | Samsara Therapeutics Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| WO-2025106477-A1 | NOVEL AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF | Samsara Therapeutics Inc. (US) | 2025-05-22 | — | — | WO | disclosed |
| WO-2024107434-A1 | AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF | Samsara Therapeutics Inc. (US) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024105007-A1 | AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF | Samsara Therapeutics Inc. (US) | 2024-05-23 | — | — | WO | disclosed |
| CN-117233299-A | Method for detecting halogenated polyphenol in drinking water by solid phase extraction-vacuum centrifugal concentration-liquid chromatography tandem mass spectrometry | 浙江大学 | 2023-12-15 | — | — | CN | disclosed |
| US-11008345-B2 | Boron-containing small molecules | ANACOR PHARMACEUTICALS, INC. (US) | 2021-05-18 | — | — | US | disclosed |
| US-11008345-B2 | Boron-containing small molecules | ANACOR PHARMACEUTICALS, INC. (US) | 2021-05-18 | — | — | US | disclosed |
| CN-108727176-B | Method for preparing 5-halogen-2, 3-dihydroxy benzaldehyde | 荆楚理工学院 | 2021-05-18 | — | — | CN | disclosed |
| CN-108610356-B | Benzoxaborole derivatives for the treatment of bacterial infections | 阿纳科制药公司 | 2021-02-26 | — | — | CN | disclosed |
| US-6004808-A | STABLE ISOLATED MAMMALIAN CELL FOR SCREENING ASSAYS; WITH HETEROLOGOUS PROMOTERS CONTROLLING GENE EXPRESSION OF G-ALPHA15 PROTEIN, A G-PROTEIN COUPLED RECEPTOR, AND A REPORTER GENE WHOSE EXPRESSION IS MODULATED BY THE G-PROTEIN | AURORA BIOSCIENCES CORPORATION (US) | 1999-12-21 | — | — | US | disclosed |
| EP-0834074-B1 | DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS | UNIV CALIFORNIA (US) | 1999-11-03 | — | — | EP | disclosed |
| US-5955604-A | Substrates for β-lactamase and uses thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-09-21 | — | — | US | disclosed |
| US-5741657-A | MEASURING GENE EXPRESSION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-04-21 | — | — | US | disclosed |
| EP-0834074-A1 | DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-04-08 | — | — | EP | disclosed |
| EP-0817785-A2 | SUBSTRATES FOR BETA-LACTAMASE AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1997048820-A1 | PROMISCUOUS G-PROTEIN COMPOSITIONS AND THEIR USE | AURORA BIOSCIENCES CORPORATION (US) | 1997-12-24 | — | — | WO | disclosed |
| WO-1996041166-A2 | DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996030540-A2 | SUBSTRATES FOR BETA-LACTAMASE AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11008345-B2 | Boron-containing small molecules | BCL6B, BTD, BROX | ERN1 3162/4885PIM1 1294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.